Evolent Health (NYSE: EVH) reported Q4 EPS of $0.08, $0.07 better than the analyst estimate of $0.01. Revenue for the quarter came in at $248.4 million versus the consensus estimate of $233.88 million.

GUIDANCE:

Evolent Health sees FY2022 revenue of $1.12-1.18 billion, versus the consensus of $1.04 billion.

For earnings history and earnings-related data on Evolent Health (EVH) click here.